• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ONTX

ONTX

Onconova Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.00

-0.00 (-0.47%)

Company Profile

CEO

Steven M. Fruchtman

IPO Date

2013-07-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.00

Prev. Close

$1.00

Day Low

$0.77

Day High

$1.00

52W Low

$0.55

52W High

$1.45

Market Cap

$0.02B

Volume

1.25M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.8%

Avg Negative

2.9%

Avg Neutral

66.2%

News Feed

Onconova Therapeutics Announces the Initial Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of ON 123300

GlobeNewsWire·5/21/2021·↑ positive

Onconova Therapeutics (ONTX): 1-For-15 Reverse Stock Split

Pulse2·5/21/2021·↓ negative

Onconova Therapeutics Announces Reverse Stock Split and Decrease in Authorized Shares

GlobeNewsWire·5/20/2021
·↑ positive

Onconova Therapeutics (ONTX) Stock: 75.04% Increase Explanation

Pulse2·5/18/2021·↑ positive

Why Onconova Therapeutic's Is Surging Today

Benzinga·5/18/2021·↑ positive

Onconova Therapeutics (ONTX) Stock: Over 30% Increase Pre-Market Explanation

Pulse2·5/18/2021·↑ positive

Onconova Therapeutics, Inc. (ONTX) CEO Steven Fruchtman on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/17/2021·↓ negative

Onconova Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

GlobeNewsWire·5/17/2021·↓ negative

Penny Stocks to Buy in May 2021? Here's 3 Big Pre-Market Gainers

PennyStocks·5/17/2021·↑ positive

Earnings Outlook for Onconova Therapeutics

Benzinga·5/14/2021·↓ negative